FDA Resumes eIND Approval for Severe-to-Critical COVID-19 Patients Use of Vyrologix™ (leronlimab) Following Full Enrollment in CytoDyn’s Phase 3 Trial
Another monoclonal antibody getting approved?
https://www.globenewswire.com/news-release/2020/12/22/2149221/0/en/FDA-Resumes-eIND-Approval-for-Severe-to-Critical-COVID-19-Patients-Use-of-Vyrologix-leronlimab-Following-Full-Enrollment-in-CytoDyn-s-Phase-3-Trial.html